Intravitreal taurolidine against experimental Staphylococcus epidermidis endophthalmitis in rabbits

Current Eye Research

Volumn 28, Issue 4, 2004, Pages 225-232

  Oguz, Halit ^a   Zeyrek, Fadile Yildiz ^a   Ozardali, Ilyas ^a   Oguz, Elif ^a   Gurkan, Tacettin ^a  

^a HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Rabbit; Staphylococcus epidermidis endophthalmitis; Taurolidine; Vancomycin

Indexed keywords

POVIDONE; TAUROLIDINE; VANCOMYCIN;

ALBINISM; ANIMAL MODEL; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; ENDOPHTHALMITIS; ENUCLEATION; EYE INFLAMMATION; HISTOPATHOLOGY; INOCULATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; SCORING SYSTEM; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; VITREOUS BODY;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; CILIARY BODY; COLONY COUNT, MICROBIAL; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; INJECTIONS; MICROBIAL SENSITIVITY TESTS; POVIDONE; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TAURINE; THIADIAZINES; VANCOMYCIN; VITREOUS BODY;

EID: 1842855303     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.28.4.225.27833     Document Type: Article

References (38)

1. Ellis MF. Topical anesthesia: A risk factor for post-cataract-extraction endophthalmitis? Clin Experiment Ophthalmol. 2003;31:125-128.
2. Sabaci G, Bayer A, Mutlu FM, Karagul S, Yildirim E. Endophthalmitis after deadly-weapon-related open-globe injuries: Risk factors, value of prophylactic antibiotics, and visual outcomes. Am J Ophthalmol. 2002;133:62-69.
3. Abu el-Asrar AM, al-Amro SA, al-Mosallam AA, al-Obeidan S. Post-traumatic endophthalmitis: Causative organisms and visual outcome. Eur J Ophthalmol. 1999;9:21-31.
4. Smith MA, Sorenson JA, D'Aversa G, Mandelbaum S, Udell I, Harrison W. Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin and intravitreal dexamethasone. J Infect Dis. 1997;175:462-466.
5. Smith MA, Sorenson JA, Lowy FD, Shakin JL, Harrison W, Jakobiec FA. Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin. Ophthalmology. 1986;93:1328-1335.
6. Karakücük S, Mirza E, Sümerkan B, Okten T. Intravitreal trovafloxacin against experimental Staphylococcus epidermidis endophthalmitis. Ophthalmic Res. 2000;32:126-131.
7. Ng EW, Samiy N, Ruoff KL, Cousins FV, Hooper DC, von Gunten S, D'Amico DJ, Baker AS. Treatment of experimental Staphylococcus epidermidis endophthalmitis with oral trovafloxacin. Am J Ophthalmol. 1998;126:278-287.
8. Meredith TA, Aguilar HE, Miller MJ, Gardner SK, Trabelsi A, Wilson LA. Comparative treatment of experimental Staphylococcus epidermidis endophthalmitis. Arch Ophthalmol. 1990;108:857-860.
9. Gibley MJ, Sanders JK. Mechanisms of antibacterial formaldehyde delivery from noxythiolin and other masked formaldehyde compounds. J Pharm Pharmacol. 1983; 35:712-717.
10. Brearley S, George RH. The rate of antibacterial action of noxythiolin and taurolin. J Hosp Infect. 1980;1:201-209.
11. Browne MK, Leslie GB, Pfirmann RW. Taurolin, a new chemotherapeutic agent. J Appl Bacteriol. 1976;41:363-368.
12. Geistlich Pharmaceuticals-Taurolin profile. Available from: URL: http://www.geistlich.ch/pharma/en/index.html. Accessed September 24, 2003.
13. Jones DS, Gorman SP, McCafferty DF, Woolfson AD. The effects of three non-antibiotic, antimicrobial agents on the surface hydrophobicity of certain microorganisms evaluated by different methods. J Appl Bacteriol. 1991;71: 218-227.
14. Bieselt R. Surgical therapy of pleural empyema with tauroline. Langenbecks Arch Chir. 1997;382:42-46.
15. Torres-Viera C, Thauvin-Eliopoulos C, Souli M, DeGirolami P, Farris MG, Wennersten CB, Sofia RD, Eliopoulos GM. Activities of taurolidine in vitro and in experimental enterococcal endocarditis. Antimicrob Agents Chemother. 2000;44:1720-1724.
16. Staubach KH. Adjuvant therapy of peritonitis with taurolidine. Modulation of mediator liberation. Langenbecks Arch Chir. 1997;382:S26-30.
17. Conlan AA, Abramor E, Delikaris P, Hurwitz SS. Taurolidine instillation as therapy for empyema thoracis. S Afr Med J. 1983;64:653-655.
18. Marti MC, Moser G, Bordigoni P. Pleural empyema and Tauroflex. Study of a new bactericidal agent. Schweitz Med Wochenschr. 1978;108:215-216.
19. Zimmermann M, Preac-Mursic V. In vitro activity of taurolidine, chlorophenol-camphor-menthol and chlorhexidine against oral pathogenic microorganisms. Arzneimittelforschung. 1992;42:1157-1159.
20. Aras C Özdamar A, Seçkin I, Devranoǧlu K, Güzel H, Özkan Ş. Retinal toxicity of taurolidine [Oral presentation, abstract]. 35. Turkish Ophthalmology Society Congress, Izmir, Turkey, 2001.
21. Hindler J. Antimicrobial susceptibility testing. In: Isenberg HD, ed. Clinical Microbiology Procedures Handbook. Washington: American Society for Microbiology; 1992: pp. 5, 16, 27.
22. Blenkharn JI. In-vitro antibacterial activity of noxythiolin and taurolidine. J Pharm Pharmacol. 1990;42:589-590.
23. Traub WH, Leonhard B, Bauer D. Taurolidine: In vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae. Chemotherapy. 1993;39:322-330.
24. Pleyer U, Mondino BJ, Adamu SA, Pitchekian-Halabi H, Engstrom RE, Glasgow BJ. Immune response to Staphylococcus epidermidis in a rabbit model. Invest Ophthalmol Vis Sci. 1992;33:2650-2663.
25. Koch AL. Spread plate technique in growth measurement. In: Gerhardt P, ed. Manual of Methods for General Bacteriology. Washington DC: American Society for Microbiology; 1981:179-207.
26. Nagaki Y, Hayasaka S, Kadoi C, Matsumoto M, Yanagisawa S, Watanabe K, Watanabe K, Hayasaka Y, Ikeda N, Sato S, Kataoka Y, Togashi M, Abe T. Bacterial endophthalmitis after small-incision cataract surgery. Effect of incision placement and intraocular lens type. J Cataract Refract Surg. 2003;29:20-26.
27. Kalpadakis P, Tsinopoulos I, Rudolph G, Schebitz K, Froehlich SJ. A comparison of endophthalmitis after phacoemulsification or extracapsular cataract extraction in a socio-economically deprived environment: A retrospective analysis of 2446 patients. Eur J Ophthalmol. 2002;12: 395-400.
28. Quie PG, Belani KK. Coagulase-negative staphylococcal adherence and persistence. J Infect Dis. 1987;156:543-547.
29. Schmidt H, Schloricke E, Fislage R, Schulze HA, Guthoff R. Effect of surface modifications of intraocular lenses on the adherence of Staphylococcus epidermidis. Zentralbl Bakteriol. 1998;287:135-145.
30. Strmen P, Hlavackova K, Ferkova S, Vavrova K, Jakabovicova E, Vrastilova M. Endophthalmitis after intraocular interventions. Klin Monatsbl Augenheilkd. 1997;211:245-249.
31. Meredith TA, Trabelsi A, Miller MJ, Aguilar E, Wilson LA. Spontaneous sterilization in experimental Staphylococcus epidermidis endophthalmitis. Invest Ophthalmol Vis Sci. 1990;31:181-186.
32. Forster RK, Abbott RL, Gelender H. Management of infectious endophthalmitis. Ophthalmology. 1980;87:313-319.
33. Monson JR, Ramsey PS, Donohue JH. Taurolidine inhibits tumour necrosis factor (TNF) toxicity-new evidence of TNF and endotoxin synergy. Eur J Surg Oncol. 1993;19: 226-231.
34. Konukoglu D, Iynem H, Ziylan E. Antioxidant status in experimental peritonitis: Effects of alpha tocopherol and taurolin. Pharmacol Res. 1999;39:247-251.
35. Dofferhoff AS, Esselink MT, de Vries-Hospers HG, van Zanten A, Bom VJ, Weits J, Vellenga E. The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes. J Antimicrob Chemother. 1993;31:373-384.
36. Bedrosian I, Sofia RD, Wolff SM, Dinarello CA. Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells. Cytokine. 1991;3: 568-575.
37. Volz J, Volz-Koster S, Kanis S, Klee D, Ahlert C, Melchert F. Modulation of tumor-induced lethality after pneumoperitoneum in a mouse model. Cancer. 2000; 89:262-266.
38. Wordemann M, Fandrey J, Jelkmann W. Tumor necrosis factor-alpha production by human hepatoma cell lines is resistant to drugs that are inhibitory to macrophages. J Interferon Cytokine Res. 1998;18:1069-1075.